Company profile
UK company 08699350, incorporated on 20 September 2013.
AKL Research & Development Limited is a UK company with status Active founded in 2013.
Company number 08699350
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
Company registered at Companies House
1 Mar 2019 to 31 May 2019
"AKLRD, a UK SME, is seeking funding to take APPA, a new drug for treating Osteoarthritis (OA), through proof of concept clinical testing. OA, a degenerative joint disease, leads to increasing immobility, chronic pain and ultimately costly joint replacement. In the UK, 8.75 million people have sought treatment for OA and it is a growing problem linked to ...
1 Aug 2014 to 31 Jan 2015
AKL, a UK SME, has developed a novel therapeutic, APPA, for the treatment of osteoarthritis, a growing chronic disease affecting more than 8.5m people in the UK. It intends to use its innovation voucher to underpin the manufacture and production of APPA.
